Contact
Please use this form to send email to PR contact of this press release:
European Commission Selects Vidac Pharma’s Tuvatexib™ Project for STEP Seal under EIC Accelerator
TO:
Max Herzberg
Vidac pharma Holding Plc
+972 54-425-7381